These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 21847544

  • 1. LOX-1: a critical player in the genesis and progression of myocardial ischemia.
    Lü J, Mehta JL.
    Cardiovasc Drugs Ther; 2011 Oct; 25(5):431-40. PubMed ID: 21847544
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation.
    Pothineni NVK, Karathanasis SK, Ding Z, Arulandu A, Varughese KI, Mehta JL.
    J Am Coll Cardiol; 2017 Jun 06; 69(22):2759-2768. PubMed ID: 28571642
    [Abstract] [Full Text] [Related]

  • 5. Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.
    Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G.
    Cardiovasc Res; 2006 Jan 06; 69(1):36-45. PubMed ID: 16324688
    [Abstract] [Full Text] [Related]

  • 6. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) transcriptional regulation by Oct-1 in human endothelial cells: implications for atherosclerosis.
    Chen J, Liu Y, Liu H, Hermonat PL, Mehta JL.
    Biochem J; 2006 Jan 01; 393(Pt 1):255-65. PubMed ID: 16173915
    [Abstract] [Full Text] [Related]

  • 7. LOX-1 and obesity.
    Yan M, Mehta JL, Hu C.
    Cardiovasc Drugs Ther; 2011 Oct 01; 25(5):469-76. PubMed ID: 21881850
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.
    Singh S, Gautam AS.
    Curr Atheroscler Rep; 2019 Jul 27; 21(10):38. PubMed ID: 31350594
    [Abstract] [Full Text] [Related]

  • 11. LOX-1 receptor: A potential link in atherosclerosis and cancer.
    Balzan S, Lubrano V.
    Life Sci; 2018 Apr 01; 198():79-86. PubMed ID: 29462603
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
    Hossain E, Ota A, Karnan S, Damdindorj L, Takahashi M, Konishi Y, Konishi H, Hosokawa Y.
    Toxicol Appl Pharmacol; 2013 Dec 15; 273(3):651-8. PubMed ID: 24145059
    [Abstract] [Full Text] [Related]

  • 14. Oxidative stress and lectin-like ox-LDL-receptor LOX-1 in atherogenesis and tumorigenesis.
    Lu J, Mitra S, Wang X, Khaidakov M, Mehta JL.
    Antioxid Redox Signal; 2011 Oct 15; 15(8):2301-33. PubMed ID: 21338316
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The splice variant LOXIN inhibits LOX-1 receptor function through hetero-oligomerization.
    Biocca S, Filesi I, Mango R, Maggiore L, Baldini F, Vecchione L, Viola A, Citro G, Federici G, Romeo F, Novelli G.
    J Mol Cell Cardiol; 2008 Mar 15; 44(3):561-70. PubMed ID: 18191942
    [Abstract] [Full Text] [Related]

  • 19. [LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis].
    Morawietz H.
    Dtsch Med Wochenschr; 2010 Feb 15; 135(7):308-12. PubMed ID: 20146162
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.